On Monday, RAPT Therapeutics Inc (NASDAQ: RAPT) was 7.24% up from the session before settling in for the closing price of $0.86. A 52-week range for RAPT has been $0.79 – $9.32.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -36.87% over the last five years. When this article was written, the company’s average yearly earnings per share was at 81.30%. With a float of $68.90 million, this company’s outstanding shares have now reached $132.01 million.
The firm has a total of 68 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
RAPT Therapeutics Inc (RAPT) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward RAPT Therapeutics Inc stocks. The insider ownership of RAPT Therapeutics Inc is 47.81%, while institutional ownership is 45.18%.
RAPT Therapeutics Inc (RAPT) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 81.30% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 42.80% during the next five years compared to -10.10% drop over the previous five years of trading.
RAPT Therapeutics Inc (NASDAQ: RAPT) Trading Performance Indicators
You can see what RAPT Therapeutics Inc (RAPT) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 4.87.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.12, a number that is poised to hit -0.14 in the next quarter and is forecasted to reach -0.68 in one year’s time.
Technical Analysis of RAPT Therapeutics Inc (RAPT)
Analysing the last 5-days average volume posted by the [RAPT Therapeutics Inc, RAPT], we can find that recorded value of 0.87 million was lower than the volume posted last year of 0.88 million. As of the previous 9 days, the stock’s Stochastic %D was 17.48%. Additionally, its Average True Range was 0.11.
During the past 100 days, RAPT Therapeutics Inc’s (RAPT) raw stochastic average was set at 8.93%, which indicates a significant decrease from 15.34% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 83.58% in the past 14 days, which was lower than the 146.29% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.1573, while its 200-day Moving Average is $1.7653. Now, the first resistance to watch is $0.9839. This is followed by the second major resistance level at $1.0417. The third major resistance level sits at $1.1087. If the price goes on to break the first support level at $0.8591, it is likely to go to the next support level at $0.7921. Now, if the price goes above the second support level, the third support stands at $0.7343.
RAPT Therapeutics Inc (NASDAQ: RAPT) Key Stats
There are 132,007K outstanding shares of the company, which has a market capitalization of 122.24 million. As of now, sales total 0 K while income totals -129,870 K. Its latest quarter income was 0 K while its last quarter net income were -53,250 K.
